Increased phospholipase A2 and lyso-phosphatidylcholine levels are associated with surfactant dysfunction in lung contusion injury in mice

Surgery (United States)

Volumn 153, Issue 1, 2013, Pages 25-35

  MacHado Aranda, David ^a   Wang, Zhengdong ^b   Yu, Bi ^a   Suresh, M V ^a   Notter, Robert H ^b,c   Raghavendran, Krishnan ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; LUNG SURFACTANT; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; SECRETORY PHOSPHOLIPASE A2; ALBUMINOID; BIOLOGICAL MARKER; PHOSPHOLIPID; SURFACTANT ASSOCIATED PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; LUNG ALVEOLUS SURFACE TENSION; LUNG COMPLIANCE; LUNG CONTUSION; LUNG INJURY; LUNG LAVAGE; LUNG PRESSURE; LUNG VOLUME; MALE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; ACUTE LUNG INJURY; ANIMAL; C57BL MOUSE; CHEMISTRY; CONTUSION; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; LUNG FUNCTION TEST; METABOLISM; PATHOPHYSIOLOGY;

ACUTE LUNG INJURY; ALBUMINS; ANIMALS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CONTUSIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; LYSOPHOSPHATIDYLCHOLINES; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHATIDYLCHOLINES; PHOSPHOLIPASES A2, SECRETORY; PHOSPHOLIPIDS; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; RESPIRATORY FUNCTION TESTS;

EID: 84870948575     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2012.05.043     Document Type: Article

References (58)

1. S.M. Cohn Pulmonary contusion: review of the clinical entity J Trauma 42 1997 973 979
2. F.R. Lewis Thoracic trauma Surg Clin North Am 62 1982 97 104
3. P.R. Miller, M.A. Croce, and T.K. Bee ARDS after pulmonary contusion: accurate measurement of contusion volume identifies high-risk patients J Trauma 51 2001 223 228 discussion 9-30
4. R.G. DePalma, D.G. Burris, H.R. Champion, and M.J. Hodgson Blast injuries N Engl J Med 352 2005 1335 1342
5. Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. The ARDS Network JAMA 283 2000 1995 2002
6. ARDS Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network N Engl J Med 342 2000 1301 1308
7. G.D. Rubenfeld, E. Caldwell, and E. Peabody Incidence and outcomes of acute lung injury N Engl J Med 353 2005 1685 1693
8. M.M. Treggiari, L.D. Hudson, and D.P. Martin Effect of acute lung injury and acute respiratory distress syndrome on outcome in critically ill trauma patients Crit Care Med 32 2004 327 331
9. G. Nakos, E.I. Kitsiouli, I. Tsangaris, and M.E. Lekka Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components Intensive Care Med 24 1998 296 303
10. G. Nakos, E. Kitsiouli, and E. Hatzidaki Phospholipases A2 and platelet-activating-factor acetylhydrolase in patients with acute respiratory distress syndrome Crit Care Med 33 2005 772 779
11. R.H. Notter Lung surfactants: basic science and clinical applications 2000 Marcel Dekker, Inc New York
12. R.H. Notter, and Z. Wang Pulmonary surfactant: physical chemistry, physiology, and replacement Rev Chem Eng 13 1997 1 118
13. K. Raghavendran, B.A. Davidson, and P.R. Knight Surfactant dysfunction in lung contusion with and without superimposed gastric aspiration correlates with severity of lung injury Shock 30 2008 508 517
14. J.J. Hoth, W.P. Hudson, and N.A. Brownlee Toll-like receptor 2 participates in the response to lung injury in a murine model of pulmonary contusion Shock 28 2007 447 452
15. G. Matute-Bello, G. Downey, and B.B. Moore An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals Am J Respir Cell Mol Biol 44 2011 725 738
16. Z. Wang, Y. Chang, A.L. Schwan, and R.H. Notter Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs Am J Respir Cell Mol Biol 37 2007 387 394
17. Z. Wang, B.A. Holm, S. Matalon, and R.H. Notter Surfactant activity and dysfunction in lung injury R.H. Notter, J.N. Finkelstein, B.A. Holm, Lung injury: mechanisms, pathophysiology, and therapy 2005 Taylor Francis Group, Inc Boca Raton (FL) 297 352
18. Z. Wang, and R.H. Notter Additivity of protein and non-protein inhibitors of lung surfactant activity Am J Respir Crit Care Med 158 1998 28 35
19. K. Raghavendran, B.A. Davidson, and J.A. Woytash The evolution of isolated, bilateral lung contusion from blunt chest trauma in rats: cellular and cytokine responses Shock 24 2005 132 138
20. J.A. Vanoirbeek, M. Rinaldi, and V. De Vooght Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases Am J Respir Cell Mol Biol 42 2010 96 104
21. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 132 1951 265 275
22. B.N. Ames Assay of inorganic phosphate, total phosphate, and phosphatases Methods Enzymol 8 1966 115 118
23. J.C. Touchstone, J.C. Chen, and K.M. Beaver Improved separation of phospholipids in thin-layer chromatography Lipids 15 1980 61 62
24. G. Enhorning Pulsating bubble technique for the evaluation of pulmonary surfactant J Appl Physiol 43 1977 198 203
25. S.B. Hall, M.S. Bermel, and Y.T. Ko Approximations in the measurement of surface tension with the pulsating bubble surfactometer J Appl Physiol 75 1993 468 477
26. C.F. Bennett, S. Mong, M.A. Clarke, L.I. Kruse, and S.T. Crooke Differential effects of manoalide on secreted and intracellular phospholipases Biochem Pharmacol 36 1987 733 740
27. K. Raghavendran, D. Willson, and R.H. Notter Surfactant therapy for acute lung injury and acute respiratory distress syndrome Crit Care Clin 27 2011 525 559
28. M. Hallman, R. Spragg, J.H. Harrell, K.M. Moser, and L. Gluck Evidence of lung surfactant abnormality in respiratory failure J Clin Invest 70 1982 673 683
29. U. Pison, W. Seeger, and R. Buchhorn Surfactant abnormalities in patients with respiratory failure after multiple trauma Am Rev Respir Dis 140 1989 1033 1039
30. W. Seeger, U. Pison, R. Buchhorn, U. Obestacke, and T. Joka Surfactant abnormalities and adult respiratory failure Lung 168 Suppl 1990 891 902
31. T.J. Gregory, W.J. Longmore, and M.A. Moxley Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome J Clin Invest 88 1991 1976 1981
32. M. Griese Pulmonary surfactant in health and human lung diseases: state of the art Eur Respir J 13 1999 1455 1476
33. A. Günther, C. Siebert, and R. Schmidt Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema Am J Respir Crit Care Med 153 1996 176 184
34. R.D. Hite, M.C. Seeds, and R.B. Jacinto Hydrolysis of surfactant-associated phosphatidylcholine by mammalian secretory phospholipases A2 Am J Physiol 275 1998 L740 L747
35. J.R. Wright, B.J. Benson, M.C. Williams, J. Goerke, and J.A. Clements Protein composition of rabbit alveolar surfactant subfractions Biochim Biophys Acta 791 1984 320 332
36. N.J. Gross, and K.R. Narine Surfactant subtypes in mice: characterization and quantitation J Appl Physiol 66 1989 342 349
37. S.B. Hall, R.W. Hyde, and R.H. Notter Changes in subphase surfactant aggregates in rabbits injured by free fatty acid Am J Respir Crit Care Med 149 1994 1099 1106
38. J.F. Lewis, M. Ikegami, and A.H. Jobe Altered surfactant function and metabolism in rabbits with acute lung injury J Appl Physiol 69 1990 2303 2310
39. E. Putman, A.J. Boere, L. van Bree, L.M.G. van Golde, and H.P. Haagsman Pulmonary surfactant subtype metabolism is altered after short-term ozone exposure Toxicol Appl Pharmacol 134 1995 132 138
40. B.A. Davidson, P.R. Knight, and Z. Wang Surfactant alterations in acute inflammatory lung injury from aspiration of acid and gastric particulates Am J Physiol Lung Cell Mol Physiol 288 2005 L699 L708
41. R.D. Hite, M.C. Seeds, and A.M. Safta Lysophospholipid generation and phosphatidylglycerol depletion in phospholipase A(2)-mediated surfactant dysfunction Am J Physiol Lung Cell Mol Physiol 288 2005 L618 L624
42. L. Arbibe, K. Koumanov, and D. Vial Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction J Clin Invest 102 1998 1152 1160
43. B.A. Holm, L. Keicher, M.Y. Liu, J. Sokolowski, and G. Enhorning Inhibition of pulmonary surfactant function by phospholipases J Appl Physiol 71 1991 317 321
44. B.A. Holm, and R.H. Notter Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity J Appl Physiol 63 1987 1434 1442
45. B.A. Holm, Z. Wang, and R.H. Notter Multiple mechanisms of lung surfactant inhibition Pediatr Res 46 1999 85 93
46. S.B. Hall, Z.R. Lu, A.R. Venkitaraman, R.W. Hyde, and R.H. Notter Inhibition of pulmonary surfactant by oleic acid: Mechanisms and characteristics J Appl Physiol 72 1992 1708 1716
47. B.A. Holm, G. Enhorning, and R.H. Notter A biophysical mechanism by which plasma proteins inhibit lung surfactant activity Chem Phys Lipids 49 1988 49 55
48. B.A. Holm, R.H. Notter, and J.H. Finkelstein Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids Chem Phys Lipids 38 1985 287 298
49. D.E. Niewoehner, K. Rice, A.A. Sinha, and D. Wangensteen Injurious effects of lysophosphatidylcholine on barrier properties of alveolar epithelium J Appl Physiol 63 1987 1979 1986
50. Z. Wang, A.L. Schwan, and L.L. Lairson Surface activity of a synthetic lung surfactant containing a phospholipase-resistant phosphonolipid analog of dipalmitoyl phosphatidylcholine Am J Physiol 285 2003 L550 L559
51. R.H. Notter, A.L. Schwan, Z. Wang, and A.J. Waring Novel phospholipase-resistant lipid/peptide synthetic lung surfactants Mini-Rev Med Chem 7 2007 932 944
52. R.H. Notter, Z. Wang, Z. Wang, J. Davy, and A.L. Schwan Synthesis and surface activity of diether-linked phosphoglycerols: potential applications for exogenous lung surfactants Bioorg Med Chem Lett 17 2007 113 117
53. W.H. Lin, S.G. Cramer, J.G. Turcotte, and R.S. Thrall A diether phosphonolipid surfactant analog, DEPN-8, is resistant to phospholipase-C cleavage Respiration 64 1997 96 101
54. J.G. Turcotte, W.H. Lin, and P.E. Pivarnik Chemical synthesis and surface activity of lung surfactant phospholipid analogs. II. Racemic N-substituted diether phosphonolipids Biochim Biophys Acta 1084 1991 1 12
55. J.A. Yu, M.R. Sadaria, and X. Meng Lung cancer cell invasion and expression of intercellular adhesion molecule-1 (ICAM-1) are attenuated by secretory phospholipase A inhibition J Thorac Cardiovasc Surg 143 2012 405 411
56. R.S. Rosenson, H. Fraser, M.A. Goulder, and C. Hislop Anti-inflammatory effects of varespladib methyl in diabetic patients with acute coronary syndrome Cardiovasc Drugs Ther 25 2011 539 544
57. D.P. Rotella SB-480848. GlaxoSmithKline Curr Opin Investig Drugs 5 2004 348 351
58. D.L. Scott, S.P. White, and J.L. Browning Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate Science 254 1991 1007 1010